EUVIMEDEUVIMED entdecken
Crossref

Trametinib as a targeted treatment in cardiac and lymphatic presentations of Noonan syndrome

Brouchoven Isabel De, Juan Lorand, Arthur Sorlin Leon Bofferding,, Damme An Van, Olivier Danhaive

Yearbook of Paediatric Endocrinology · 30.09.2025

DOI: 10.1530/ey.22.2.5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von Brouchoven Isabel De und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

De, B. I., Lorand, J., Bofferding,, A. S. L., Van, D. A., & Danhaive, O. (2025). Trametinib as a targeted treatment in cardiac and lymphatic presentations of Noonan syndrome. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.2.5

Vancouver

De BI, Lorand J, Bofferding, ASL, Van DA, Danhaive O. Trametinib as a targeted treatment in cardiac and lymphatic presentations of Noonan syndrome. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.2.5

BibTeX
@article{De2025,
  author = {De, Brouchoven Isabel and Lorand, Juan and Bofferding,, Arthur Sorlin Leon and Van, Damme An and Danhaive, Olivier},
  title = {Trametinib as a targeted treatment in cardiac and lymphatic presentations of Noonan syndrome},
  journal = {Yearbook of Paediatric Endocrinology},
  year = {2025},
  doi = {10.1530/ey.22.2.5}
}
Kostenlos starten →